Dr. Jay Bhattacharya – the Stanford professor who is President-elect Donald Trump’s nominee for the directorship of the ...

The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...

Referring to research proposals by Chinese scientists and their US collaborators, and the emergence of the same kind of virus ...

BioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...

BioNTech settles with NIH and UPenn over Comirnaty royalties, paying $750M to NIH and $400M to UPenn for 2020-2023, with ...

Senator Rand Paul got into a tense exchange with former NIH Associate Director for Science Policy Dr. Carrie Wolinetz over ...

For years, we’ve exposed the federal government’s role — especially the Intelligence Community — in concealing the origins of ...

BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...

Much of the NIH-funded research on long COVID has focused on observing and understanding the disease. Some patients and doctors say the research should pivot toward finding new treatments and drugs.

Pfizer has agreed to reimburse BioNTech for $364.5 million of the claimed royalties paid to NIH and $170.0 million of the claimed royalties paid to the University of Pennsylvania. Write to Dean Seal ...